Drug intelligence / Profile preview

WP103

Development stage
Unknown
Lead developer
Wanbangde Pharmaceutical Group
Modality
Small Molecules
Administration
Injection
01

Overview

WP103 is a small molecule acetylcholinesterase inhibitor (AChEI) being developed by Wanbangde for the treatment of Neonatal Hypoxic-Ischemic Encephalopathy (HIE). It is a novel injection formulation of huperzine A, a sesquiterpene alkaloid that naturally occurs in the firmoss *Huperzia serrata*. By inhibiting the enzyme acetylcholinesterase, WP103 increases the concentration of acetylcholine in the central nervous system, which is intended to provide neuroprotective effects and mitigate brain injury caused by oxygen deprivation in newborns. The drug has been granted Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) by the US FDA. Its Investigational New Drug (IND) application has been accepted by the FDA, moving the candidate into clinical development.

Other names
New Huperzine A Injection新石杉碱甲注射液

Beyond the preview

Go deeper on WP103.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WP103.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call